Trillium Software and Collibra Integrate Data Governance

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Trillium Software and Collibra Integrate Data Governance and Data Quality Offerings to Improve Data Accountability and Business Process

BILLERICA, MA--(Marketwired - May 29, 2013) - Trillium Software® , a business of Harte-Hanks, Inc. ( NYSE : HHS ) and a leading provider of Total Data Quality ™ solutions, and Collibra , a leading provider of data governance software, today announced an alliance to address the demand for data governance initiatives and enable customers of both companies to leverage data as a strategic enterprise asset. 

In today's competitive environment, organizations are looking for new ways to increase revenue from existing customers. As the definition of a customer varies from one part of the organization to another, business managers are demanding a more unified view in order to better understand customer needs, gain trust and sustain retention. By combining data governance and data quality management toolsets, organizations can create both a contextual and holistic view of the data to drive business process improvement, reduce operational costs, improve customer retention while increasing revenue.

"Data Quality, master data management and regulatory compliance are driving the demand for data governance projects today and yet the lack of effective data governance is one of the main reasons why these very initiatives fail," said Benny Verhaeghe, vice president of sales & marketing at Collibra. "By combining Trillium Software's best-of-breed data quality solutions with Collibra's leading data governance software, we can together provide customers with a powerful integrated solution for data quality management."

The integration between the Trillium Software System ® and Collibra's Data Governance Center will enable customers to add policies to business rules management by business stakeholders. This will make data profiling results more easily accessible by business people and provide traceability between business rules, data assets, systems and business definitions, as well as address issue management resolution. Unlike similar offerings from platform vendors, the alliance provides customers with a focused solution and eliminates the need to buy additional products and services.

"The impact of data governance has made data quality more relevant than ever to the business user, who requires increased accessibility and visibility into data and information," said David Pietropaolo, vice president of global alliances at Trillium Software. "By combining Collibra's Data Governance Center with our solution, customers can continuously control, improve and achieve the benefits of having high quality data and information to drive better results for their business processes."

The product integration connector between the Collibra Data Governance Center 4 and the Trillium Software System is already complete. To learn more about the alliance please visit http://www.trilliumsoftware.com/WorkArea/Down...px?id=9674

About Collibra Collibra is a Data Governance software company bringing Business and IT together to govern data as an enterprise asset. As a best of breed vendor, Collibra provides the Data Steward organization with a technology platform that supports their activities. Collibra is a Gartner Cool vendor for Enterprise Information Management. For more information visit http://www.collibra.com or contact us at contact@collibra.com

About Harte-Hanks Harte-Hanks ® is a worldwide direct and targeted marketing company that provides direct marketing services and shopper advertising opportunities to local, regional, national and international consumer and business-to-business marketers. Visit the Harte-Hanks Web site at http://www.harte-hanks.com or call (800) 456-9748.

About Trillium Software Trillium Software ® is a business of Harte-Hanks, and the leading best-of-breed enterprise data quality software and services provider in the world. Trillium's data quality experts help organizations achieve increased business value from their global data management initiatives by providing enterprise data profiling and data cleansing software solutions that collaborate with existing data systems and applications.

Trillium's data quality suite of products enable business executives and information technology professionals to profile, govern, manage, cleanse, and visualize data for CRM, MDM, regulatory and compliance, data warehouse and business intelligence initiatives. The company offers industry-specific business solutions that help solve data problems experienced by financial services, insurance, risk, healthcare and retail professionals. For more information about Trillium Software and its offerings, call (978) 436-8900 in the United States and in the United Kingdom call +44 (0) 118 940 7666, or visit Trillium Software online at http://www.trilliumsoftware.com .

This document may contain trademarks that are owned or licensed by Harte-Hanks, Inc. and its subsidiaries, including, without limitation, Trillium Software ® , Trillium Software System ® , Total Data Quality ™ , and other names and marks. All other brand names, product names, or trademarks belong to their respective holders.

Media Contacts: Michael Antonellis Harte-Hanks Trillium Software (978) 439-3813 michael_antonellis@trilliumsoftware.com Benny Verhaeghe Collibra (347) 491-3828 benny@collibra.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 24

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 18

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 21

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 34

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 26

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 27

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading

Top 5 Most Recently Viewed Articles

Boeing Aims to Raise $25 Billion Through Stock and Debt Sales

Updated Category News Views 83

Boeing's Strategic Move to Raise Funds Boeing recently filed a registration statement with U.S. market regulators to raise up to $25 billion through a mix of debt securities and stock offerings. This decision comes as the company aims to shore up its financial resources amid considerable debt maturities on the horizon. Financial Context for the Offering Though the...

Continue Reading
Novartis Achieves Strong Q2 Growth with Enhanced Guidance for 2025

Updated Category News Views 628

Impressive Q2 Financial Results from Novartis Novartis has recently shared its stellar performance for the second quarter, showcasing remarkable growth tantamount to an impressive 11% increase in net sales when accounting for constant currencies and a 12% increase in USD. Core operating income soared by 21%, reflecting a robust business framework and strategic focus on...

Continue Reading
Insightful Fireside Chat on Upexi's Future Strategies Ahead

Updated Category News Views 85

Upexi to Host Engaging Fireside Chat with Leadership Team Upexi, Inc. (NASDAQ: UPXI), a dynamic player in the consumer products and cryptocurrency sectors, has officially announced an upcoming fireside chat featuring its CEO, Allan Marshall, and Chief Strategy Officer, Brian Rudick. This event is set to take place on an upcoming Thursday at 11:00 a.m. ET, aiming to delve...

Continue Reading
Genius Group Faces Securities Law Violations Claims

Updated Category News Views 20

Another Day, Another Lawsuit: Genius Group's Legal Trouble Step right up, folks, it's time for the latest courtroom drama involving Genius Group Limited (NYSE American: GNS). You know the drill. A company gets too cocky, spouts off a bunch of bloated nonsense, and now they're knee-deep in securities law muck. This time it's Genius, and the folks at DJS Law Group are...

Continue Reading
Understanding Chart Industries' Stock Sentiment and Trends

Updated Category News Views 141

The Current Sentiment for Chart Industries Chart Industries, renowned for its innovation in energy and industrial gas solutions, has recently seen intriguing shifts in its stock dynamics. As of the latest report, the short percent of float for Chart Industries (GTLS) has notably decreased by 25.37%. This decline highlights that investors may be gaining confidence in the...

Continue Reading